Doha, Qatar: Qatar Science & Technology Park (QSTP), a member of Qatar Foundation, in partnership with Merck, a number one science and know-how firm, introduced the launch of the QSTP x Merck FemTech Accelerator, a devoted accelerator designed to help deep tech and affect pushed FemTech startups addressing crucial unmet wants in women’s health and remodeling health outcomes for ladies throughout the MENA area.
The programme will establish and help up to 30 main FemTech startups creating breakthrough options throughout key women’s health domains, specializing in improvements powered by synthetic intelligence, robotics, and supplies science. Selected corporations will obtain entry to superior scaling help, market entry pathways, and clinically aligned pilot alternatives to help business growth into Qatar, with pathways to the broader area.
Beyond supporting particular person startups, the initiative is designed to generate and observe measurable affect at scale, aligned with Qatar Foundation’s mission to enhance women’s health outcomes throughout the area. Through a multi-country method, the QSTP x Merck FemTech Accelerator will allow deep-tech startups to be piloted, validated, and adopted throughout a number of markets, addressing women’s health challenges at each regional and international ranges.
Leveraging QSTP’s innovation ecosystem and Merck’s international scientific and healthcare experience, chosen startups will profit from curated mentorship, publicity to regional healthcare stakeholders, and alternatives to discover collaboration inside Qatar’s health and analysis panorama. The accelerator will even facilitate engagement with related nationwide establishments and ecosystem partners.
Aligned with Qatar Foundation’s innovation and healthcare priorities, the accelerator goals to place the nation as a regional and international hub for women’s health innovation, whereas addressing the pressing want for better funding, analysis, and commercialisation in FemTech, one of many fastest-growing and most impactful sectors in international health know-how.
President, QSTP, Rama Chakaki mentioned: “At QSTP, we believe that meaningful innovation is inclusive. This accelerator is designed to support high-potential startups and generate measurable, scalable impact on women’s health across multiple markets. Leveraging Qatar’s growing innovation ecosystem alongside Merck’s global scientific leadership, we are creating pathways for FemTech solutions to be piloted, validated, and adopted at regional and global scale.”
General Manager, Gulf, Merck, Ahmed Aboelfadl mentioned: “Women’s health remains one of the most under-addressed areas in healthcare innovation globally. Through this partnership with QSTP, Merck is proud to support the growth of FemTech companies developing science- and technology-led solutions that can meaningfully improve health outcomes for women. By combining global scientific expertise with regional collaboration, this initiative will help accelerate innovation, enable real-world impact, and strengthen the ecosystem for women’s health across Qatar and the wider MENA region.”
The programme will characteristic an intensive two-week immersion in Doha, the place chosen founders will have interaction with stakeholders from Qatar’s healthcare ecosystem, together with clinicians, regulators, traders, and innovation leaders, to validate market alternatives and put together for commercialisation.